AI company Zebra Medical Vision has scored another approval from the FDA, this time for its AI alert that can help diagnose pneumothoraces based on chest X-rays.
Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient's breath has been given a major funding boost.
With genetic analysis and diagnostic tests now available via mail order, how will this trend towards the proactive consumer impact the evolution of health management?
